1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
CAS: 74389-68-7
Ref. 01-4006552
25mg | 163,00 € | ||
100mg | 421,00 € | ||
500mg | 1.518,00 € |
Información del producto
- PAF (C₁₆)
- (2R)-2-Acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate
- 1-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine
- 1-O-Hexadecyl-2-Acetyl-Sn-Glycero-3-Phosphocholine
- 1-O-Hexadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine
- 1-O-Hexadecyl-2-acetyl-sn-glycerophosphocholine
- 1-O-Hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine
- 1-O-Hexadecyl-platelet-activating factor
- 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (7R)-
- 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-
- Ver más sinónimos
- Blood platelet-activating factor
- Blood platelet-activating factor acether
- C<sub>16</sub>-PAF
- C<sub>16</sub>-PAF acether
- Ethanaminium, 2-[[[[(2R)-2-(acetyloxy)-3-(hexadecyloxy)propyl]oxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt
- PAF acether
- Paf 16
- Paf C 16
- Platelet-activating factor
- Platelet-activating factor (1-O-hexadecyl)
- Platelet-activating factor acether
Accelerated cognitive decline in Alzheimer’s patients is associated with accumulation of choline-containing phospholipids. One of them, C16-PAF, is specifically elevated in brains of Alzheimer’s patients. Enhanced exposure to this platelet-activating factor ultimately leads to neuronal death.
Propiedades químicas
Consulta técnica sobre: 01-4006552 1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.